Your browser doesn't support javascript.
loading
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events.
Takahashi, Takuto; Al-Kofahi, Mahmoud; Jaber, Mutaz; Bratrude, Brandi; Betz, Kayla; Suessmuth, Yvonne; Yu, Alison; Neuberg, Donna S; Choi, Sung W; Davis, Jeffrey; Duncan, Christine; Giller, Roger; Grimley, Michael; Harris, Andrew C; Jacobsohn, David; Lalefar, Nahal; Farhadfar, Nosha; Pulsipher, Michael A; Shenoy, Shalini; Petrovic, Aleksandra; Schultz, Kirk R; Yanik, Gregory A; Blazar, Bruce R; Horan, John T; Watkins, Benjamin; Langston, Amelia; Qayed, Muna; Kean, Leslie S.
Affiliation
  • Takahashi T; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Al-Kofahi M; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Jaber M; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN.
  • Bratrude B; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN.
  • Betz K; Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN.
  • Suessmuth Y; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Yu A; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Neuberg DS; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Choi SW; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Davis J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA.
  • Duncan C; Department of Pediatrics, Emory University, Atlanta, GA.
  • Giller R; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Grimley M; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Harris AC; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Jacobsohn D; Department of Pediatrics, University of Michigan, Ann Arbor, MI.
  • Lalefar N; BC Children's Hospital, University of British Columbia, Vancouver, Canada.
  • Farhadfar N; Division Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
  • Pulsipher MA; Department of Pediatrics, Harvard Medical School, Boston, MA.
  • Shenoy S; Center for Cancer and Blood Disorders, Children Hospital of Colorado, University of Colorado, Aurora, CO.
  • Petrovic A; Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH.
  • Schultz KR; Pediatric Bone Marrow Transplant and Cellular Therapy Program, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Yanik GA; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC.
  • Blazar BR; Division of Pediatric Hematology/Oncology, UCSF Benioff Children's Hospital Oakland, University of California San Francisco, Oakland, CA.
  • Horan JT; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL.
  • Watkins B; Huntsman Cancer Institute, Spencer Fox Eccles School of Medicine, Primary Children's Hospital, University of Utah, Salt Lake City, UT.
  • Langston A; Division Hematology/Oncology, Washington University School of Medicine, St Louis, MO.
  • Qayed M; Department of Pediatrics, Seattle Children's Hospital and Fred Hutch Cancer Center, Seattle, WA.
  • Kean LS; BC Children's Hospital, University of British Columbia, Vancouver, Canada.
Blood ; 142(8): 700-710, 2023 08 24.
Article in En | MEDLINE | ID: mdl-37319437

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Epstein-Barr Virus Infections / Graft vs Host Disease Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Morocco

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Epstein-Barr Virus Infections / Graft vs Host Disease Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Blood Year: 2023 Type: Article Affiliation country: Morocco